lidocaine has been researched along with Epicondylitis, Lateral Humeral in 24 studies
Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.
Excerpt | Relevance | Reference |
---|---|---|
"The aim of the study was to compare the effects of corticosteroid injection with lidocaine injection in treating tennis elbow." | 9.27 | Comparison Between Corticosteroid and Lidocaine Injection in the Treatment of Tennis Elbow: A Randomized, Double-Blinded, Controlled Trial. ( Hsieh, LF; Huang, V; Kuo, YC; Lee, CC; Liu, YC; Liu, YF, 2018) |
"The aim of the study was to compare the effects of corticosteroid injection with lidocaine injection in treating tennis elbow." | 5.27 | Comparison Between Corticosteroid and Lidocaine Injection in the Treatment of Tennis Elbow: A Randomized, Double-Blinded, Controlled Trial. ( Hsieh, LF; Huang, V; Kuo, YC; Lee, CC; Liu, YC; Liu, YF, 2018) |
"To evaluate and compare effects of US and CD guided intratendinous injections with sclerosing polidocanol and a local anaesthetic (lidocaine + epinephrine), in patients with tennis elbow." | 5.13 | Pain relief after intratendinous injections in patients with tennis elbow: results of a randomised study. ( Alfredson, H; Fahlström, M; Ohberg, L; Zeisig, E, 2008) |
"In a prospective, randomized, double-blind study of radial epicondylalgia (tennis elbow), 109 patients with an average symptom duration of 8 months were considered for treatment with a single 1-mL injection of the steroid triamcinolone combined with either lidocaine or bupivacaine." | 5.08 | Cortisone injection with anesthetic additives for radial epicondylalgia (tennis elbow). ( Adalberth, G; Buch, F; Mallmin, H; Sölveborn, SA, 1995) |
"A popular choice for lateral epicondylitis (LE), corticosteroid injections have been associated with prominent side effects, which has led to the conception of modalities like platelet-rich plasma (PRP)." | 2.94 | PRP versus steroids in a deadlock for efficacy: long-term stability versus short-term intensity-results from a randomised trial. ( Acharya, A; Gupta, PK; Khanna, V; Khillan, K; Roy, S; Sambandam, SN, 2020) |
"Lidocaine is a local anaesthetic with analgesic but no anti-inflammatory properties." | 2.72 | Lidocaine iontophoresis mediates analgesia in lateral epicondylalgia treatment. ( Ferslew, KE; Kalbfleisch, JH; Panus, PC; Yarrobino, TE, 2006) |
"Lateral epicondylitis is a common complaint, with an annual incidence between 1% and 3% in the general population." | 2.71 | Cost effectiveness of interventions for lateral epicondylitis: results from a randomised controlled trial in primary care. ( Adèr, HJ; Assendelft, WJ; Bouter, LM; Korthals-de Bos, IB; Rutten-van Mölken, MP; Smidt, N; van der Windt, DA; van Tulder, MW, 2004) |
"In a prospective randomized study of lateral epicondylitis, 120 patients were treated with 2 mL lidocaine (Group A, n=60) or 1 mL lidocaine combined with 1 mL triamcinolone (Group B, n=60)." | 2.70 | Local injection treatment for lateral epicondylitis. ( Altay, T; Günal, I; Oztürk, H, 2002) |
"It has previously been reported that lateral epicondylitis may be diagnosed with colour Doppler ultrasonography (US) by detecting hyperaemia inside the common extensor origin (CEO)." | 1.35 | Effect of glucocorticosteroid injections in tennis elbow verified on colour Doppler ultrasonography: evidence of inflammation. ( Bliddal, H; Qvistgaard, E; Torp-Pedersen, ST; Torp-Pedersen, TE, 2008) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (8.33) | 18.7374 |
1990's | 3 (12.50) | 18.2507 |
2000's | 10 (41.67) | 29.6817 |
2010's | 8 (33.33) | 24.3611 |
2020's | 1 (4.17) | 2.80 |
Authors | Studies |
---|---|
da Luz, DC | 1 |
de Borba, Y | 1 |
Ravanello, EM | 1 |
Daitx, RB | 1 |
Döhnert, MB | 1 |
Gupta, PK | 1 |
Acharya, A | 1 |
Khanna, V | 1 |
Roy, S | 1 |
Khillan, K | 1 |
Sambandam, SN | 1 |
Yelland, M | 1 |
Rabago, D | 1 |
Ryan, M | 1 |
Ng, SK | 1 |
Vithanachchi, D | 1 |
Manickaraj, N | 1 |
Bisset, L | 1 |
Yi, R | 1 |
Bratchenko, WW | 1 |
Tan, V | 1 |
Hsieh, LF | 2 |
Kuo, YC | 1 |
Lee, CC | 1 |
Liu, YF | 1 |
Liu, YC | 1 |
Huang, V | 1 |
van Schie, P | 1 |
Benders, KEM | 1 |
van den Bekerom, MPJ | 1 |
Martin, JI | 1 |
Atilano, L | 1 |
Merino, J | 1 |
Gonzalez, I | 1 |
Iglesias, G | 1 |
Areizaga, L | 1 |
Bully, P | 1 |
Grandes, G | 1 |
Andia, I | 1 |
Louw, F | 1 |
Zhu, J | 1 |
Hu, B | 1 |
Xing, C | 1 |
Li, J | 1 |
Bisset, LM | 1 |
Coppieters, MW | 1 |
Vicenzino, B | 1 |
Dogramaci, Y | 1 |
Kalaci, A | 1 |
Savaş, N | 1 |
Duman, IG | 1 |
Yanat, AN | 1 |
SINGER, M | 1 |
Korthals-de Bos, IB | 1 |
Smidt, N | 1 |
van Tulder, MW | 1 |
Rutten-van Mölken, MP | 1 |
Adèr, HJ | 1 |
van der Windt, DA | 1 |
Assendelft, WJ | 1 |
Bouter, LM | 1 |
Zeisig, E | 2 |
Ohberg, L | 2 |
Alfredson, H | 2 |
Yarrobino, TE | 1 |
Kalbfleisch, JH | 1 |
Ferslew, KE | 1 |
Panus, PC | 1 |
Tonks, JH | 1 |
Pai, SK | 1 |
Murali, SR | 1 |
Fahlström, M | 1 |
Torp-Pedersen, TE | 1 |
Torp-Pedersen, ST | 1 |
Qvistgaard, E | 1 |
Bliddal, H | 1 |
Kivi, P | 1 |
Sölveborn, SA | 1 |
Buch, F | 1 |
Mallmin, H | 1 |
Adalberth, G | 1 |
Finestone, H | 1 |
Helfenstein, S | 1 |
Altay, T | 1 |
Günal, I | 1 |
Oztürk, H | 1 |
Price, R | 1 |
Sinclair, H | 1 |
Heinrich, I | 1 |
Gibson, T | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Efficacy of a Whole Upper Limb Stretching Protocol for Lateral Epicondylitis[NCT05238090] | 40 participants (Anticipated) | Interventional | 2022-03-30 | Not yet recruiting | |||
Pilot Randomized Controlled Trial to Evaluate Safety and Efficacy of Percutaneous Needle Tenotomy With Platelet Rich Plasma (Leukocyte Depleted)in Epicondylitis[NCT01945528] | Phase 3 | 86 participants (Actual) | Interventional | 2014-04-30 | Completed | ||
Tennis Elbow, Randomized Study: Needling With and Without Platelet-rich Plasma After Failure of Up-to-date Rehabilitation[NCT03987256] | 58 participants (Anticipated) | Interventional | 2020-01-01 | Recruiting | |||
Percutaneous Interruption of the Coracohumeral Ligament for the Treatment of Frozen Shoulder.[NCT04549051] | 49 participants (Anticipated) | Interventional | 2020-11-17 | Active, not recruiting | |||
The Use of Activated Platelet Rich Plasma (PRP) in Human Autologous Fat Transfer[NCT01461785] | Phase 2/Phase 3 | 25 participants (Actual) | Interventional | 2012-04-30 | Completed | ||
Eccentric Exercise in Epicondylitis: Direct Application By Physical Therapist Vs Self-Application By Patient[NCT03996928] | 20 participants (Anticipated) | Interventional | 2017-01-01 | Recruiting | |||
Safety and Effects of PDRN(Polydeoxyribonucleotide) Injection in Patient With Elbow Epicondylitis in Randomized Double-blind Active-control Comparative Study[NCT02492945] | Phase 4 | 40 participants (Actual) | Interventional | 2015-06-30 | Completed | ||
Treatment of Tendon Injury Using Allogenic Adipose-derived Mesenchymal Stem Cells: Phase II Double-Blind Placebo-Controlled Randomized Clinical Trials.[NCT02298023] | Phase 2 | 24 participants (Actual) | Interventional | 2014-09-30 | Completed | ||
Treatment of Tendon Injury Using Allogenic Adipose-derived Mesenchymal Stem Cells(ALLO-ASC):A Pilot Study[NCT01856140] | Early Phase 1 | 12 participants (Actual) | Interventional | 2013-05-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Pain during activity will be evaluated by visual analog scale (active pain VAS). The active pain visual analog scale change from baseline to 3 months after intervention is the primary outcome. Visual analog scale is scored 0 to 10, higher scored meaning worse outcome. Negative values in change of pain during activity indicate improvement in pain. (NCT02298023)
Timeframe: Baseline and 3 months after intervention
Intervention | units on a scale (Mean) |
---|---|
Mesenchymal Stem Cell Group | -1.4 |
Active Control (Fibrin Glue) Group | -1.5 |
Control (Normal Saline )Group | -3.0 |
Functional score of the shoulder was assessed by American Shoulder and Elbow Surgeons shoulder score which is a questionnaire dedicated to the functional evaluation of the shoulder. It is scored from 0 to 100, higher scores meaning better outcome. (NCT02298023)
Timeframe: Baseline, 6 weeks, 12 weeks, 6, 12, 24 months after intervention
Intervention | score on a scale (Mean) | |||||
---|---|---|---|---|---|---|
baseline | week 6 | month 3 | month 6 | month 12 | year 2 | |
Active Control (Fibrin Glue) Group | 64.7 | 70.6 | 73.7 | 76.7 | 76.0 | 80.0 |
Control (Normal Saline )Group | 54.7 | 65.9 | 63.6 | 63.9 | 74.4 | 89.3 |
Mesenchymal Stem Cell Group | 58.9 | 52.4 | 67.9 | 63.4 | 70.6 | 71.6 |
Shoulder function is assessed by DASH score which is questionnaire dedicated to evaluate the function of the upper extremity. It is scored from 0 (no disability) to 100 (most severe disability). (NCT02298023)
Timeframe: Baseline, 6 weeks, 12 weeks, 6, 12, 24 months after intervention
Intervention | score on a scale (Mean) | |||||
---|---|---|---|---|---|---|
baseline | week 6 | month 3 | month 6 | month 12 | year 2 | |
Active Control (Fibrin Glue) Group | 35.2 | 25.8 | 19.2 | 19.8 | 20.5 | 22.8 |
Control (Normal Saline )Group | 37.6 | 28.1 | 28.3 | 27.1 | 20.3 | 20.1 |
Mesenchymal Stem Cell Group | 32.3 | 36.7 | 24.0 | 25.0 | 31.1 | 20.3 |
Pain during activity assessed by visual analog scale (VAS), scored 0 to 10, higher scores meaning worse outcome (NCT02298023)
Timeframe: Baseline, 6 weeks, 12 weeks, 6, 12, 24 months after intervention
Intervention | units on a scale (Mean) | |||||
---|---|---|---|---|---|---|
baseline | week 6 | month 3 | month 6 | month 12 | year 2 | |
Active Control (Fibrin Glue) Group | 4.7 | 3.2 | 3.2 | 2.8 | 3.2 | 3.2 |
Control (Normal Saline )Group | 6.6 | 4.6 | 3.6 | 4.3 | 3.1 | 1.1 |
Mesenchymal Stem Cell Group | 5.7 | 6.0 | 4.4 | 4.3 | 3.7 | 4.4 |
Pain during rest assessed by visual analog scale (VAS), scored 0 to 10, higher scores meaning worse outcome. (NCT02298023)
Timeframe: Baseline, 6 weeks, 12 weeks, 6, 12, 24 months after intervention
Intervention | units on a scale (Mean) | |||||
---|---|---|---|---|---|---|
baseline | week 6 | month 3 | month 6 | month 12 | year 2 | |
Active Control (Fibrin Glue) Group | 2.4 | 2.2 | 1.9 | 1.4 | 1.8 | 0.8 |
Control (Normal Saline )Group | 3.6 | 3.0 | 2.7 | 2.4 | 1.3 | 0.5 |
Mesenchymal Stem Cell Group | 3.9 | 4.0 | 2.8 | 2.9 | 2.9 | 2.0 |
Shoulder function is assessed by UCLA shoulder score which is a composite of range of motion examination and questionnaire dedicated to evaluate the function of the shoulder. It is scored from 0 to 35, higher scores meaning better shoulder function. (NCT02298023)
Timeframe: Baseline, 6 weeks, 12 weeks, 6, 12, 24 months after intervention
Intervention | score on a scale (Mean) | |||||
---|---|---|---|---|---|---|
baseline | week 6 | month 3 | month 6 | month 12 | year 2 | |
Active Control (Fibrin Glue) Group | 19.0 | 22.3 | 23.6 | 23.6 | 24.5 | 24.6 |
Control (Normal Saline )Group | 17.5 | 22.9 | 21.4 | 22.8 | 28.0 | 31.3 |
Mesenchymal Stem Cell Group | 20.3 | 20.0 | 26.4 | 22.7 | 23.6 | 24.4 |
Self reported pain intensity during activity will be evaluated by visual analogue scale (0 = no pain, 10 = pain as bad as can be), higher scores meaning worse outcome. (NCT01856140)
Timeframe: Baseline, 6 weeks, 12 weeks after intervention
Intervention | score on a scale (Mean) | ||
---|---|---|---|
Baseline | Post-injection 6 weeks | Post-injection 12 weeks | |
1 Million Cells/ml of ALLO-ASC | 3.57 | 2.93 | 1.68 |
10 Million Cells/ml of ALLO-ASC | 3.02 | 1.60 | 0.87 |
"Defect areas were measured as the largest defect of the common extensor tendon. Higher value means larger defect area.~With the patient supine position with the elbow in 30' flexion and full pronation, the cephalic end of the ultrasound transducer was placed on the lateral epicondyle and the long axis of the transducer was aligned with the long axis of radius. The alignment of the transducer and radius was achieved by visualizing contours of the bony structures. Multiple cross-sectional images were saved by shifting the transducer medio-laterally by 2mm at a time. Acquiring images were repeated three times.~Among the saved images, one image showing the largest defect were selected for every patients at every time points. Manual measurements of the defect area were conducted by tracking the perimeter using ImageJ 1.48 software (National Institutes of Health, http://imagej.nih.gov/ij/) and were repeated three times by two examiners in random orders and then, averaged." (NCT01856140)
Timeframe: Baseline, 6 weeks, and 12 weeks after the intervention
Intervention | mm^2 (Mean) | ||
---|---|---|---|
Baseline | Post-injection 6weeks | Post-injection 12 weeks | |
1 Million Cells/ml of ALLO-ASC | 4197 | 4163 | 2381 |
10 Million Cells/ml of ALLO-ASC | 5246 | 4383 | 2516 |
"Defect areas were measured as the largest defect of the common extensor tendon. Higher value means larger defect area.~With the patient supine position with the elbow in 30' flexion and full pronation, the transducer was placed on the proximal forearm just distal to the radial head, aligning the long axis of the transducer perpendicular to the long axis of the forearm. Viewing the round radius at the horizontal center, the transducer was shifted proximally by 2mm and multiple images were saved after the transducer passed the radial head until it slid over the prominence. Acquiring images were repeated three times.~Among the saved images, one image showing the largest defect were selected for every patients at every time points. Manual measurements of the defect area were conducted by tracking the perimeter using ImageJ 1.48 software (National Institutes of Health, http://imagej.nih.gov/ij/) and were repeated three times by two examiners in random orders and then, averaged." (NCT01856140)
Timeframe: Baseline, 6 weeks, and 12 weeks after the intervention
Intervention | mm^2 (Mean) | ||
---|---|---|---|
Baseline | Post-injection 6 weeks | Post-injection 12 weeks | |
1 Million Cells/ml of ALLO-ASC | 3726 | 3797 | 2703 |
10 Million Cells/ml of ALLO-ASC | 5018 | 2849 | 2223 |
The Modified Mayo clinic performance index for the elbow measures pain, motion, stability, and daily functions. (0 to 100) Higher score means better function. (NCT01856140)
Timeframe: Baseline, 6 weeks, 12 weeks after the intervention
Intervention | score on a scale (Median) | ||
---|---|---|---|
Baseline | Post-injection 6 weeks | Post-injection 12 weeks | |
1 Million Cells/ml of ALLO-ASC | 57.92 | 83.75 | 87.92 |
10 Million Cells/ml of ALLO-ASC | 70.00 | 90.41 | 91.67 |
16 trials available for lidocaine and Epicondylitis, Lateral Humeral
Article | Year |
---|---|
Iontophoresis in lateral epicondylitis: a randomized, double-blind clinical trial.
Topics: Anesthetics, Local; Anti-Inflammatory Agents; Dexamethasone; Double-Blind Method; Female; Gels; Hand | 2019 |
PRP versus steroids in a deadlock for efficacy: long-term stability versus short-term intensity-results from a randomised trial.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Female; Hand Strength; Humans; Injections, | 2020 |
Prolotherapy injections and physiotherapy used singly and in combination for lateral epicondylalgia: a single-blinded randomised clinical trial.
Topics: Adult; Anesthetics, Local; Combined Modality Therapy; Exercise Therapy; Female; Follow-Up Studies; G | 2019 |
Deep Friction Massage Versus Steroid Injection in the Treatment of Lateral Epicondylitis.
Topics: Adult; Aged; Anesthetics, Local; Anti-Inflammatory Agents; Cortisone; Female; Friction; Hand Strengt | 2018 |
Comparison Between Corticosteroid and Lidocaine Injection in the Treatment of Tennis Elbow: A Randomized, Double-Blinded, Controlled Trial.
Topics: Adrenal Cortex Hormones; Adult; Aged; Double-Blind Method; Female; Hand Strength; Humans; Injections | 2018 |
Platelet-rich plasma versus lidocaine as tenotomy adjuvants in people with elbow epicondylopathy: a randomized controlled trial.
Topics: Adult; Anesthetics, Local; Double-Blind Method; Female; Humans; Lidocaine; Male; Middle Aged; Platel | 2019 |
Platelet-rich plasma versus lidocaine as tenotomy adjuvants in people with elbow epicondylopathy: a randomized controlled trial.
Topics: Adult; Anesthetics, Local; Double-Blind Method; Female; Humans; Lidocaine; Male; Middle Aged; Platel | 2019 |
Platelet-rich plasma versus lidocaine as tenotomy adjuvants in people with elbow epicondylopathy: a randomized controlled trial.
Topics: Adult; Anesthetics, Local; Double-Blind Method; Female; Humans; Lidocaine; Male; Middle Aged; Platel | 2019 |
Platelet-rich plasma versus lidocaine as tenotomy adjuvants in people with elbow epicondylopathy: a randomized controlled trial.
Topics: Adult; Anesthetics, Local; Double-Blind Method; Female; Humans; Lidocaine; Male; Middle Aged; Platel | 2019 |
Ultrasound-guided, minimally invasive, percutaneous needle puncture treatment for tennis elbow.
Topics: Adolescent; Adult; Anesthetics, Local; Calcinosis; Elbow Joint; Female; Glucocorticoids; Humans; Lid | 2008 |
Sensorimotor deficits remain despite resolution of symptoms using conservative treatment in patients with tennis elbow: a randomized controlled trial.
Topics: Adult; Aged; Anesthetics, Local; Ergonomics; Female; Humans; Lidocaine; Male; Middle Aged; Physical | 2009 |
Treatment of lateral epicondilitis using three different local injection modalities: a randomized prospective clinical trial.
Topics: Adult; Analysis of Variance; Anesthetics, Local; Chi-Square Distribution; Female; Glucocorticoids; H | 2009 |
Cost effectiveness of interventions for lateral epicondylitis: results from a randomised controlled trial in primary care.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Anesthetics, Local; Cost of Illness; Cost-Benefit | 2004 |
Lidocaine iontophoresis mediates analgesia in lateral epicondylalgia treatment.
Topics: Algorithms; Analgesia; Analysis of Variance; Anesthetics, Local; Female; Humans; Iontophoresis; Lido | 2006 |
Steroid injection therapy is the best conservative treatment for lateral epicondylitis: a prospective randomised controlled trial.
Topics: Adult; Anesthetics, Local; Anti-Inflammatory Agents; Drug Combinations; Humans; Injections; Lidocain | 2007 |
Pain relief after intratendinous injections in patients with tennis elbow: results of a randomised study.
Topics: Adult; Aged; Anesthetics, Local; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; | 2008 |
Cortisone injection with anesthetic additives for radial epicondylalgia (tennis elbow).
Topics: Adolescent; Adult; Aged; Bupivacaine; Double-Blind Method; Drug Combinations; Female; Humans; Lidoca | 1995 |
Cortisone injection with anesthetic additives for radial epicondylalgia (tennis elbow).
Topics: Adolescent; Adult; Aged; Bupivacaine; Double-Blind Method; Drug Combinations; Female; Humans; Lidoca | 1995 |
Cortisone injection with anesthetic additives for radial epicondylalgia (tennis elbow).
Topics: Adolescent; Adult; Aged; Bupivacaine; Double-Blind Method; Drug Combinations; Female; Humans; Lidoca | 1995 |
Cortisone injection with anesthetic additives for radial epicondylalgia (tennis elbow).
Topics: Adolescent; Adult; Aged; Bupivacaine; Double-Blind Method; Drug Combinations; Female; Humans; Lidoca | 1995 |
Cortisone injection with anesthetic additives for radial epicondylalgia (tennis elbow).
Topics: Adolescent; Adult; Aged; Bupivacaine; Double-Blind Method; Drug Combinations; Female; Humans; Lidoca | 1995 |
Cortisone injection with anesthetic additives for radial epicondylalgia (tennis elbow).
Topics: Adolescent; Adult; Aged; Bupivacaine; Double-Blind Method; Drug Combinations; Female; Humans; Lidoca | 1995 |
Cortisone injection with anesthetic additives for radial epicondylalgia (tennis elbow).
Topics: Adolescent; Adult; Aged; Bupivacaine; Double-Blind Method; Drug Combinations; Female; Humans; Lidoca | 1995 |
Cortisone injection with anesthetic additives for radial epicondylalgia (tennis elbow).
Topics: Adolescent; Adult; Aged; Bupivacaine; Double-Blind Method; Drug Combinations; Female; Humans; Lidoca | 1995 |
Cortisone injection with anesthetic additives for radial epicondylalgia (tennis elbow).
Topics: Adolescent; Adult; Aged; Bupivacaine; Double-Blind Method; Drug Combinations; Female; Humans; Lidoca | 1995 |
Local injection treatment for lateral epicondylitis.
Topics: Adult; Anesthetics, Local; Anti-Inflammatory Agents; Female; Humans; Injections; Lidocaine; Male; Pr | 2002 |
Local injection treatment of tennis elbow--hydrocortisone, triamcinolone and lignocaine compared.
Topics: Adult; Drug Combinations; Elbow; Female; Humans; Hydrocortisone; Injections; Lidocaine; Male; Middle | 1991 |
Local injection treatment of tennis elbow--hydrocortisone, triamcinolone and lignocaine compared.
Topics: Adult; Drug Combinations; Elbow; Female; Humans; Hydrocortisone; Injections; Lidocaine; Male; Middle | 1991 |
Local injection treatment of tennis elbow--hydrocortisone, triamcinolone and lignocaine compared.
Topics: Adult; Drug Combinations; Elbow; Female; Humans; Hydrocortisone; Injections; Lidocaine; Male; Middle | 1991 |
Local injection treatment of tennis elbow--hydrocortisone, triamcinolone and lignocaine compared.
Topics: Adult; Drug Combinations; Elbow; Female; Humans; Hydrocortisone; Injections; Lidocaine; Male; Middle | 1991 |
Local injection treatment of tennis elbow--hydrocortisone, triamcinolone and lignocaine compared.
Topics: Adult; Drug Combinations; Elbow; Female; Humans; Hydrocortisone; Injections; Lidocaine; Male; Middle | 1991 |
Local injection treatment of tennis elbow--hydrocortisone, triamcinolone and lignocaine compared.
Topics: Adult; Drug Combinations; Elbow; Female; Humans; Hydrocortisone; Injections; Lidocaine; Male; Middle | 1991 |
Local injection treatment of tennis elbow--hydrocortisone, triamcinolone and lignocaine compared.
Topics: Adult; Drug Combinations; Elbow; Female; Humans; Hydrocortisone; Injections; Lidocaine; Male; Middle | 1991 |
Local injection treatment of tennis elbow--hydrocortisone, triamcinolone and lignocaine compared.
Topics: Adult; Drug Combinations; Elbow; Female; Humans; Hydrocortisone; Injections; Lidocaine; Male; Middle | 1991 |
Local injection treatment of tennis elbow--hydrocortisone, triamcinolone and lignocaine compared.
Topics: Adult; Drug Combinations; Elbow; Female; Humans; Hydrocortisone; Injections; Lidocaine; Male; Middle | 1991 |
8 other studies available for lidocaine and Epicondylitis, Lateral Humeral
Article | Year |
---|---|
Letter to the Editor Involving the Article "Comparison Between Corticosteroids and Lidocaine Injection in the Treatment of Tennis Elbow: A Randomized, Double-Blinded, Controlled Trial".
Topics: Adrenal Cortex Hormones; Humans; Lidocaine; Pain Measurement; Tennis Elbow | 2018 |
Comparison Between Corticosteroid and Lidocaine Injection in the Treatment of Tennis Elbow: A Randomized, Double-Blinded, Controlled Trial.
Topics: Adrenal Cortex Hormones; Double-Blind Method; Humans; Lidocaine; Tennis Elbow | 2018 |
The occasional prolotherapy for lateral epicondylosis (tennis elbow).
Topics: Adult; Anesthetics, Local; Female; Glucose; Humans; Injections, Intralesional; Lidocaine; Regenerati | 2014 |
TENNIS ELBOW.
Topics: Drug Therapy; Elbow Joint; Humans; Hyaluronoglucosaminidase; Hydrocortisone; Joint Diseases; Lidocai | 1964 |
Extensor origin vascularity related to pain in patients with Tennis elbow.
Topics: Anesthetics, Local; Blood Flow Velocity; Case-Control Studies; Female; Hand Strength; Humans; Inject | 2006 |
Effect of glucocorticosteroid injections in tennis elbow verified on colour Doppler ultrasonography: evidence of inflammation.
Topics: Adult; Aged; Anesthetics, Local; Drug Combinations; Female; Glucocorticoids; Humans; Injections, Int | 2008 |
The etiology and conservative treatment of humeral epicondylitis.
Topics: Adult; Athletic Injuries; Betamethasone; Female; Forearm Injuries; Humans; Indomethacin; Lidocaine; | 1983 |
Spray bottle epicondylitis. Diagnosing and treating workers in pain.
Topics: Adrenal Cortex Hormones; Adult; Biomechanical Phenomena; Ergonomics; Female; Household Work; Humans; | 1994 |